Status:
COMPLETED
A Study to Demonstrate the Efficacy and Safety of Motilitone®
Lead Sponsor:
Dong-A ST Co., Ltd.
Conditions:
Functional Dyspepsia
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia. The study is conducted with following methods: multi-ce...
Eligibility Criteria
Inclusion
- Roman III criteria
- One or more conditions are applied: epigastralgia, burning feelings in the solar plexus early satiety, uncomfortable fullness
- No organic lesion
Exclusion
- has been administered or was administered within a month
- had a surgery that might affect gastrointestinal motility
- Tegaserod
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
389 Patients enrolled
Trial Details
Trial ID
NCT01817465
Start Date
August 1 2012
End Date
March 1 2014
Last Update
January 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Medical Center
Suwon, South Korea